Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

BITBBitwise Bitcoin ETF

NYSE · CIK 0001763415
Filer categoryLarge accelerated filer
Entity typeoperating
SIC6221 Commodity Contracts Brokers & Dealers
FY end1231
XBRL facts59

Identity from submissions API

NameBitwise Bitcoin ETF
CIK0001763415
TickersBITB
ExchangesNYSE
Entity typeoperating
CategoryLarge accelerated filer
SIC6221 Commodity Contracts Brokers & Dealers
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone415-707-3663
Website—
Investor website—
Owner org09 Crypto Assets
Flags—
Description—
Insider transactions (issuer)0
Insider transactions (owner)0

Former names

  • BITWISE BITCOIN ETP TRUST (2021-10-14T00:00:00.000Z → 2023-10-26T00:00:00.000Z)
  • BITWISE BITCOIN ETF TRUST (2019-01-10T00:00:00.000Z → 2020-01-14T00:00:00.000Z)
Business address
250 MONTGOMERY STREET
SUITE 200
SAN FRANCISCO
CA
94104
CA
Mailing address
250 MONTGOMERY STREET
SUITE 200
SAN FRANCISCO
CA
94104
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

66 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-06 10-Q 10-Q 0001193125-26-451777 001-41902 261531693 34 4470949 1 1
2026-08-07 10-Q 10-Q 0001193125-26-340183 001-41902 261253722 34 4409435 1 1
2026-05-06 10-Q 10-Q 0001193125-26-209293 001-41902 26949484 34 4121673 1 1
2026-03-27 424I 424I 0001193125-26-129293 333-287903 26808200 33 130356 1 1
2026-03-11 10-K/A 10-K/A 0001193125-26-102028 001-41902 26743065 34 224270 1 1
2026-03-02 10-K 10-K 0001193125-26-085335 001-41902 26707404 34 5914292 1 1
2025-11-10 10-Q 10-Q 0001193125-25-274482 001-41902 251467149 34 8084001 1 1
2025-09-03 RW REGISTRATION WITHDRAWAL REQUEST 0001213900-25-083916 333-282553 251288692 NE 6911
2025-08-07 10-Q 10-Q 0001193125-25-175490 001-41902 251194817 34 7909809 1 1
2025-08-01 424B3 PROSPECTUS 0001213900-25-070105 333-287903 251172983 33 1035815
2025-07-31 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002430 333-287903 251173499 33 2039
2025-07-31 CORRESP filename1.htm 0001213900-25-069761 5780
2025-07-31 S-3/A AMENDMENT NO. 3 TO FORM S-3 0001213900-25-069756 333-287903 251170287 33 1228563 1 1
2025-07-29 S-3/A AMENDMENT NO. 2 TO FORM S-3 0001213900-25-068806 333-287903 251163025 33 1100706
2025-06-23 CORRESP filename1.htm 0001213900-25-056638 32586
2025-06-23 S-3/A AMENDMENT NO. 1 TO FORM S-3 0001213900-25-056635 333-287903 251064674 33 1214167
2025-06-18 UPLOAD filename1.pdf 0000000000-25-006394 333-287903 44946
2025-06-10 S-3 REGISTRATION STATEMENT 0001213900-25-052948 333-287903 251036569 33 1121854
2025-05-12 10-Q 10-Q 0000950170-25-068780 001-41902 25933602 34 7242170 1 1
2025-03-28 424I 424I 0001193125-25-067093 333-260235 25786487 33 38934
2025-03-28 10-K/A 10-K/A 0000950170-25-046761 001-41902 25785901 34 285956 1 1
2025-03-18 10-K 10-K 0000950170-25-040572 001-41902 25745933 34 9041265 1 1
2025-02-14 8-K 8-K 1.02,7.01 0000950170-25-021165 001-41902 25628231 34 44701
2024-11-26 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-24-102302 333-282553 241498011 33 1599668
2024-11-20 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001213900-24-095688,2024-11-20 9999999995-24-003521 333-260235 241481997 33 2059
2024-11-20 424B3 PROSPECTUS 0001213900-24-100387 333-260235 241478447 33 1044891
2024-11-08 10-Q 10-Q 0000950170-24-124134 001-41902 241440964 34 4332028 1 1
2024-11-08 POS AM POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 0001213900-24-095688 333-260235 241438869 33 1116533
2024-10-08 S-1 REGISTRATION STATEMENT 0001999371-24-013150 333-282553 241360966 33 2021507
2024-08-30 8-K 8-K 1.01,7.01,9.01 0000950170-24-102165 001-41902 241267816 34 190819 1 1
2024-08-08 10-Q 10-Q 0000950170-24-093606 001-41902 241187196 34 4246946 1 1
2024-05-13 10-Q 10-Q 0000950170-24-058601 001-41902 24938798 34 3851148 1 1
2024-03-27 10-K 10-K 0000950170-24-037294 001-41902 24791552 34 1675418 1 1
2024-01-10 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-01-10 17:00:00 9999999995-24-000079 333-260235 24527893 33 2039
2024-01-10 424B3 PROSPECTUS 0001999371-24-000346 333-260235 24527341 33 1038441
2024-01-10 POS EX POST-EFFECTIVE AMENDMENT 0001999371-24-000344 333-260235 24527316 33 1729702
2024-01-10 CERT NYSE ARCA CERTIFICATION 0001143362-24-000015 001-41902 24527071 34 29460
2024-01-09 CORRESP filename1.htm 0001999371-24-000265 5684
2024-01-09 CORRESP filename1.htm 0001999371-24-000250 55482
2024-01-09 S-1/A AMENDMENT TO FORM S-1 0001999371-24-000248 333-260235 24522047 33 1453115
2024-01-08 UPLOAD filename1.pdf 0000000000-24-000274 333-260235 46641
2024-01-08 CORRESP filename1.htm 0001839882-24-000525 251157
2024-01-08 S-1/A AMENDMENT TO FORM S-1 0001839882-24-000524 333-260235 24518365 33 2048314
2024-01-05 UPLOAD filename1.pdf 0000000000-24-000197 333-260235 65114
2023-12-29 8-A12B FORM 8-A12B 0001999371-23-001337 001-41902 231528681 34 35771
2023-12-29 S-1/A AMENDMENT TO FORM S-1 0001999371-23-001336 333-260235 231528519 33 2302095
2023-12-29 CORRESP filename1.htm 0001999371-23-001326 207261
2023-12-29 S-1/A AMENDMENT TO FORM S-1 0001999371-23-001324 333-229180 231528027 33 2302083
2023-12-14 UPLOAD filename1.pdf 0000000000-23-013621 333-260235 69873
2023-12-04 CORRESP filename1.htm 0001999371-23-000737 224771
2023-12-04 S-1/A AMENDMENT TO FORM S-1 0001999371-23-000735 333-260235 231463104 33 2167708
2023-11-14 UPLOAD filename1.pdf 0000000000-23-012481 333-260235 95516
2023-10-26 CORRESP filename1.htm 0001839882-23-028269 171515
2023-10-25 S-1/A AMENDMENT TO FORM S-1 0001387131-23-012681 333-260235 231346899 33 827764
2023-09-29 UPLOAD filename1.pdf 0000000000-23-010835 333-260235 58158
2021-10-14 S-1 REGISTRATION STATEMENT 0001387131-21-009995 333-260235 211322594 33 863179
2020-01-14 RW rw.htm 0001493152-20-000557 333-229180 20525249 NE 13302
2019-09-11 S-1/A forms-1a.htm 0001493152-19-013955 333-229180 191087105 33 836251
2019-09-10 S-1/A forms-1a.htm 0001493152-19-013946 333-229180 191086257 33 11845091
2019-04-16 S-1/A forms-1a.htm 0001493152-19-005505 333-229180 19751755 33 762645
2019-03-28 FWP fwp.htm 0001493152-19-004055 333-229180 19709652 34 48103
2019-03-28 FWP fwp.htm 0001493152-19-004052 333-229180 19709617 34 61758
2019-03-28 FWP fwp.htm 0001493152-19-004050 333-229180 19709614 34 19981
2019-03-28 FWP fwp.htm 0001493152-19-004048 333-229180 19709611 34 61391
2019-01-10 FWP fwp.htm 0001493152-19-000432 333-229180 19520863 34 115941
2019-01-10 S-1 forms-1.htm 0001493152-19-000408 333-229180 19519331 33 566701

Latest XBRL company facts

One latest value per concept from companyfacts (59 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 68.58M 2026-11-01 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
dei EntityPublicFloat Entity Public Float USD 4.26B 2025-06-30 2025 FY 10-K/A 2026-03-11 0001193125-26-102028
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 506,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 200 2023-12-31 2023 FY 10-K 2024-03-27 0000950170-24-037294
us-gaap Assets Assets USD 3.18B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap AssetsHeldInTrust Assets Held-in-trust USD 1.00B 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085335
us-gaap AssetsNet Net Assets USD 3.17B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap Cash Cash USD 0 2025-09-30 2025 Q3 10-Q 2025-11-10 0001193125-25-274482
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap CommonStockNoParValue Common Stock, No Par Value USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 69.89M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 69.89M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap CommonStockValue Common Stock, Value, Issued USD 72.38B 2024-09-30 2024 Q3 10-Q 2024-11-08 0000950170-24-124134
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD -172.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap IncreaseDecreaseInManagementAndIncentiveFeesPayable IncreaseDecreaseInManagementAndIncentiveFeesPayable USD -91,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap IncreaseDecreaseInOperatingAssets Increase (Decrease) in Operating Assets USD -176.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap IncreaseDecreaseInPayableForInvestmentPurchased IncreaseDecreaseInPayableForInvestmentPurchased USD 61.43M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-10 0001193125-25-274482
us-gaap InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement USD 2.81M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001193125-26-340183
us-gaap InvestmentCompanyExpenseOffsetArrangement Investment Company, Expense Offset Arrangement USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001193125-26-340183
us-gaap InvestmentCompanyExpenseRatioExcludingIncentiveFee Investment Company, Expense Ratio Excluding Incentive Fee pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-02 0001193125-26-085335
us-gaap InvestmentCompanyExpenseRatioIncludingIncentiveFee Investment Company, Expense Ratio Including Incentive Fee pure 0.002 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap InvestmentCompanyGainLossOnInvestmentPerShare Investment Company, Gain (Loss) on Investment, Per Share USD/shares -2.17 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare Investment Company, Investment Income (Loss) from Operations, Per Share USD/shares -2.23 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap InvestmentCompanyInvestmentIncomeLossPerShare Investment Company, Investment Income (Loss), Per Share USD/shares -0.06 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap InvestmentCompanyInvestmentIncomeLossRatio Investment Company, Investment Income (Loss) Ratio pure -0.002 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap InvestmentCompanyTotalReturn Investment Company, Total Return pure -0.047 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap InvestmentIncomeNet Investment Income, Net USD -4.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap InvestmentOwnedAtCost Investment Owned, at Cost USD 2.03B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap InvestmentOwnedAtFairValue Investment Owned, at Fair Value USD 3.17B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap InvestmentOwnedPercentOfNetAssets Investment Owned, Percent of Net Assets pure 1 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap Liabilities Liabilities USD 14.13M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap NetAssetValuePerShare Net Asset Value Per Share USD/shares 45.34 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -125.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 125.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -176.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap OperatingExpenses Operating Expenses USD 4.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap PartnersCapitalAccountPeriodIncreaseDecrease Increase (Decrease) in Partners' Capital USD 21.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap PartnersCapitalAccountRedemptions Partners' Capital Account, Redemptions USD 1.10B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap PartnersCapitalAccountSaleOfUnits Partners' Capital Account, Sale of Units USD 1.08B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap PartnersCapitalAccountUnits Partners' Capital Account, Units shares 4 2023-12-31 2023 FY 10-K 2024-03-27 0000950170-24-037294
us-gaap PartnersCapitalAccountUnitsPeriodIncreaseDecrease Partners' Capital Account, Units, Period Increase (Decrease) shares -890,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap PartnersCapitalAccountUnitsRedeemed Partners' Capital Account, Units, Redeemed shares 26.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap PartnersCapitalAccountUnitsSaleOfUnits Partners' Capital Account, Units, Sale of Units shares 26.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap PaymentsForPurchaseOfInvestmentOperatingActivity PaymentsForPurchaseOfInvestmentOperatingActivity USD 789.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 941.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap ProceedsFromDispositionOfInvestmentOperatingActivity ProceedsFromDispositionOfInvestmentOperatingActivity USD 914.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 816.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 200 2023-11-09 2023-12-31 2023 FY 10-K 2024-03-27 0000950170-24-037294
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -176.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD 32.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap SponsorFees Sponsor Fees USD 4.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 83,556.83 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap TransferOfInvestments Transfer from Investments USD 1.57M 2024-01-10 2024-09-30 2024 Q3 10-Q 2024-11-08 0000950170-24-124134
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -204.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451777

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →